# Fasted Bioavailability Study of Cilostazol Tablets, 50mg

> **NCT00685802** · PHASE1 · COMPLETED · sponsor: **Mutual Pharmaceutical Company, Inc.** · enrollment: 32 (actual)

## Conditions studied

- Therapeutic Equivalency, Healthy

## Interventions

- **DRUG:** Cilostazol 50 mg Tablets
- **DRUG:** Cilostazol (Pletal®) 50 mg Tablets

## Key facts

- **NCT ID:** NCT00685802
- **Lead sponsor:** Mutual Pharmaceutical Company, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2009-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00685802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00685802, "Fasted Bioavailability Study of Cilostazol Tablets, 50mg". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00685802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*